BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31992246)

  • 1. Key genes with prognostic values in suppression of osteosarcoma metastasis using comprehensive analysis.
    Li M; Jin X; Li H; Wu G; Wang S; Yang C; Deng S
    BMC Cancer; 2020 Jan; 20(1):65. PubMed ID: 31992246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of critical genes associated with human osteosarcoma metastasis based on integrated gene expression profiling.
    Fan H; Lu S; Wang S; Zhang S
    Mol Med Rep; 2019 Aug; 20(2):915-930. PubMed ID: 31173206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative analyses of key genes and regulatory elements in fluoride-affected osteosarcoma.
    Li M; Jin X; Guo F; Wu G; Wu L; Deng S
    J Cell Biochem; 2019 Sep; 120(9):15397-15409. PubMed ID: 31037778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma.
    Yang H; Zhao L; Zhang Y; Li FF
    Cancer Med; 2021 Aug; 10(16):5696-5711. PubMed ID: 34258887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Analysis of Key mRNAs and lncRNAs in Osteosarcoma Response to Preoperative Chemotherapy with Prognostic Values.
    Li M; Cheng WT; Li H; Zhang Z; Lu XL; Deng SS; Li J; Yang CH
    Curr Med Sci; 2021 Oct; 41(5):916-929. PubMed ID: 34671904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating age‑induced differentially expressed genes and potential molecular mechanisms in osteosarcoma based on integrated bioinformatics analysis.
    Wang JS; Duan MY; Zhong YS; Li XD; Du SX; Xie P; Zheng GZ; Han JM
    Mol Med Rep; 2019 Apr; 19(4):2729-2739. PubMed ID: 30720085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALOX5AP suppresses osteosarcoma progression via Wnt/β-catenin/EMT pathway and associates with clinical prognosis and immune infiltration.
    Han GD; Dai J; Hui HX; Zhu J
    J Orthop Surg Res; 2023 Jun; 18(1):446. PubMed ID: 37344882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A support vector machine classifier for the prediction of osteosarcoma metastasis with high accuracy.
    He Y; Ma J; Ye X
    Int J Mol Med; 2017 Nov; 40(5):1357-1364. PubMed ID: 28901446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of potential key genes associated with osteosarcoma based on integrated bioinformatics analyses.
    Hu G; Cheng Z; Wu Z; Wang H
    J Cell Biochem; 2019 Aug; 120(8):13554-13561. PubMed ID: 30920023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALOX5AP is an Indicator for High CD8 Lymphocyte Infiltration and "Hot" Tumor Microenvironment in Osteosarcoma: A Bioinformatic Study.
    Chen Y; Zeng C; Zhang X; Hua Q
    Biochem Genet; 2023 Dec; 61(6):2363-2381. PubMed ID: 37041365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated analysis of gene expression and genomic aberration data in osteosarcoma (OS).
    Xiong Y; Wu S; Du Q; Wang A; Wang Z
    Cancer Gene Ther; 2015 Nov; 22(11):524-9. PubMed ID: 26427513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of CD20, ECM, and ITGA as Biomarkers for Osteosarcoma by Integrating Transcriptome Analysis.
    Wang DW; Yu SY; Cao Y; Yang L; Liu W; Er XQ; Yao GJ; Bi ZG
    Med Sci Monit; 2016 Jun; 22():2075-85. PubMed ID: 27314445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of PSMD14 as a potential novel prognosis biomarker and therapeutic target for osteosarcoma.
    Gong Y; Wei ZR
    Cancer Rep (Hoboken); 2022 Jul; 5(7):e1522. PubMed ID: 34383385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A risk signature-based on metastasis-associated genes to predict survival of patients with osteosarcoma.
    Shi Y; He R; Zhuang Z; Ren J; Wang Z; Liu Y; Wu J; Jiang S; Wang K
    J Cell Biochem; 2020 Jul; 121(7):3479-3490. PubMed ID: 31898371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics integrated analysis to investigate candidate biomarkers and associated metabolites in osteosarcoma.
    Wang J; Gong M; Xiong Z; Zhao Y; Xing D
    J Orthop Surg Res; 2021 Jul; 16(1):432. PubMed ID: 34225733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell Differentiation Trajectory-Associated Molecular Classification of Osteosarcoma.
    Xu A; Qian C; Lin J; Yu W; Jin J; Liu B; Tao H
    Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma.
    Lei T; Qian H; Lei P; Hu Y
    Cancer Sci; 2021 Nov; 112(11):4785-4798. PubMed ID: 34506683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of differentially expressed genes in the development of osteosarcoma using RNA-seq.
    Yang Y; Zhang Y; Qu X; Xia J; Li D; Li X; Wang Y; He Z; Li S; Zhou Y; Xie L; Yang Z
    Oncotarget; 2016 Dec; 7(52):87194-87205. PubMed ID: 27888627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory network of differentially expressed genes in metastatic osteosarcoma.
    Yao P; Wang ZB; Ding YY; Ma JM; Hong T; Pan SN; Zhang J
    Mol Med Rep; 2015 Mar; 11(3):2104-10. PubMed ID: 25434727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG methylation patterns are associated with gene expression variation in osteosarcoma.
    Wang Q
    Mol Med Rep; 2017 Jul; 16(1):901-907. PubMed ID: 28560411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.